glp-1 news today oct 2 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1R Race in 2025: 8 – 2025 Pharmacy in Focus Report:

Enhancements may include PRP (Vampire Facial), Exosomes, Rejuran (Salmon DNA)

Here is a timeline of when certain side effects and studies relating to the drugs health impacts first emerged

2010 Apr;151(4):1473-86 Madsen LW, Knauf JA, Gotfredsen C, Pilling A, Sjgren I, Andersen S, Andersen L, de Boer AS, Manova K, Barlas A, Vundavalli S, Nyborg NC, Knudsen LB, Moelck AM, Fagin JA

Melanage Peel This superficial skin-lightening peel treats melasma and other skin discoloration that may be caused by hormones, sun exposure, or genetics

This is the one that quietly disqualifies most programs

The push for change comes after a 2023 decision by the Biden administration to ban compounding pharmacies from producing 19 research peptides due to safety concerns